Surgical treatment of peritoneal carcinomatosis from gastric cancer. Int J Surg Oncol 2012;2012:405652
Date
07/11/2012Pubmed ID
22778938Pubmed Central ID
PMC3388312DOI
10.1155/2012/405652Scopus ID
2-s2.0-84866238640 (requires institutional sign-in at Scopus site) 6 CitationsAbstract
Peritoneal carcinomatosis from gastric cancer is considered a fatal disease with limited treatment options. Recent advances in the understanding of the disease process, systemic chemotherapy, and application of cytoreductive surgery and hyperthermic chemoperfusion have shown promising results in the management of this difficult disease. Novel therapies such as extensive intraperitoneal lavage and intraperitoneal targeted agents are being applied in the management of this disease. We review the current literature in this field and describe the rationale behind some of these advances.